Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.8%

5 terminated/withdrawn out of 131 trials

Success Rate

90.6%

+4.1% vs industry average

Late-Stage Pipeline

19%

25 trials in Phase 3/4

Results Transparency

2%

1 of 48 completed trials have results

Key Signals

14 recruiting1 with results

Enrollment Performance

Analytics

N/A
36(45.6%)
Phase 3
15(19.0%)
Phase 2
10(12.7%)
Phase 4
10(12.7%)
Phase 1
8(10.1%)
79Total
N/A(36)
Phase 3(15)
Phase 2(10)
Phase 4(10)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (131)

Showing 20 of 131 trials
NCT07560072Not ApplicableNot Yet Recruiting

A Scalable Trans Diagnostic Intervention Targeting Adolescent Agency Supported by Conversational AI (AGENCIA)

Role: lead

NCT07559110Not ApplicableNot Yet Recruiting

Supplementation With Salicornia Extract Rich in Polyphenols (B-Salicornia) to Improve Vascular Health in Patients With Dyslipidemia Who Are Not Candidates for Drug Treatment (Low to Moderate Risk)

Role: lead

NCT07521969Not ApplicableRecruiting

Out-patiente Management for Gangrenous Acute Appendicitis: The PENDI-CSI II Randomized Clinical Trial.

Role: lead

NCT07478588Not ApplicableCompleted

Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet

Role: lead

NCT07396571Not Yet Recruiting

Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae

Role: lead

NCT03540485Phase 1Terminated

Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis

Role: lead

NCT05225961Phase 4Active Not Recruiting

ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

Role: lead

NCT07384702Phase 2Not Yet Recruiting

Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia

Role: lead

NCT04478721Phase 3Completed

Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins

Role: lead

NCT05210439Phase 4Active Not Recruiting

Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

Role: lead

NCT07353424Not ApplicableRecruiting

A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polyphenol-rich Salicornia Extract in the Progression of Cognitive Decline in a Cohort of Patients With Lacunar Infarcts (SALACUNAR)

Role: lead

NCT05186857Active Not Recruiting

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

Role: lead

NCT06999317Not Yet Recruiting

CARAMEL: Retrospective Study for Personalized Risk Assessment of Cardiovascular Disease in Menopausal and Perimenopausal Women Using Real World Data

Role: collaborator

NCT07218679Not ApplicableActive Not Recruiting

Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients

Role: lead

NCT07175012Not ApplicableCompleted

ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory Diseases

Role: collaborator

NCT07153406Phase 3Not Yet Recruiting

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Role: lead

NCT06423898Phase 4Recruiting

Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

Role: lead

NCT05514366Not ApplicableCompleted

Influence of Inspiratory Pause on Ventilatory Efficiency in Robotic Surgery. A Prospective Paired Study.

Role: lead

NCT05511610Not ApplicableCompleted

MAAS Method (Minimal-flow Auto-control Anesthesia System) for the Administration of Desflurane and Sevoflurane

Role: lead

NCT06602310Not ApplicableTerminated

Utility of Preanestes@s2.0, a Web Based Application for Preoperative Assessment.

Role: lead